NEO

Health Tech Company Medivolve Finalizes Acquisition of CalVax Licensed Marbella Pharmacy

Retrieved on: 
Monday, August 16, 2021
People, Multimedia, THE, THIS, CEO, Maintenance, Vaccination, Company, OTC, COVID-19, FRA, Phrase, NEO, Ownership, Acquisition, View, Patient, Legislation, Technology, Health, Physician, Software as a service, Vaccine, Pharmaceutical industry, Hospital, Medical device

Medivolve Closes Marbella Pharmacy Deal Supporting Next Phase of Growth in Combining Data-Driven Clinical Diagnostics, Physician Recommendations, and Prescription Medications to Help People Live Healthier Lives

Key Points: 
  • Medivolve Closes Marbella Pharmacy Deal Supporting Next Phase of Growth in Combining Data-Driven Clinical Diagnostics, Physician Recommendations, and Prescription Medications to Help People Live Healthier Lives
    TORONTO, Aug. 16, 2021 /PRNewswire/ - Medivolve, Inc. ("Medivolve" or the "Company") (NEO: MEDV) (OTC: COPRF) (FRA: 4NC), a healthcare technology and services company, is pleased to announce on August 13, 2021, it closed the previously announced acquisition of Marbella ("Marbella" or the "Pharmacy"), an open-door retail pharmacy.
  • The combination of Marbella's unique pharmaceuticals and Medivolve's growth plans in the health tech space will be truly powerful.
  • As consideration for the acquisition of the Pharmacy, Medivolve has agreed to: (i) immediately issue 2 million Medivolve common shares to the shareholders of Marbella; and (ii) within 45 days of closing, pay cash consideration of US$275,000 to the Marbella shareholders.
  • In addition, Medivolve has agreed to pay the Marbella shareholders a fee of US$5.00 per serviced COVID-19 vaccination conducted through the Marbella pharmacy license for a period of 60 months post closing.

Cybin Inc. Announces 2021 First Quarter Financial Results and Business Highlights

Retrieved on: 
Saturday, August 14, 2021
Biotechnology, General Health, Health, Method, Time, EDGAR, Health Canada, Lists of diseases, Shuping Yang commencement speech controversy, NASDAQ, Net, U.S. Securities and Exchange Commission, Forward-looking statement, Tryptamine, Elgin Mental Health Center, CEO, SEDAR, News, NYSE, Company, TSX, Patent, Food, Disease, NYSE American, Psychiatry, COVID-19, Therapy, Ergoline, Mission statement, NEO, Research, Nature, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Patient, Growth, Attention, Psilocybin, Madsen v. Women's Health Center, Inc., Risk, Inc., Depression, International Financial Reporting Standards, Safety, Phenethylamine, International, TMS, Cryptocurrency, Holding company, Pharmaceutical industry

Cybin Inc. ( NEO:CYBN ) (NYSE AMERICAN:CYBN) (Cybin or the Company), a biotechnology company focused on progressing psychedelic therapeutics, announces the unaudited financial results for the three-month period ended June 30, 2021.

Key Points: 
  • Cybin Inc. ( NEO:CYBN ) (NYSE AMERICAN:CYBN) (Cybin or the Company), a biotechnology company focused on progressing psychedelic therapeutics, announces the unaudited financial results for the three-month period ended June 30, 2021.
  • Doug Drysdale, CEO of Cybin stated, During the past several months, Cybin has garnered a great deal of attention as an emerging leader in the psychedelic therapeutics space.
  • Any references to quality, consistency, efficacy and safety of potential products do not imply that Cybin verified such in clinical trials or that Cybin will complete such trials.
  • If Cybin cannot obtain the approvals or research necessary to commercialize its business, it may have a material adverse effect on Cybins performance and operations.

The Parent Company Extends Retail Footprint into the Central Valley with DELI by Caliva

Retrieved on: 
Friday, August 13, 2021
Culture, Multimedia, THE, Athlete, Judgement, Perception, Federation, CEO, SEDAR, Parent company guarantee, News, SAN, Company, Risk, LinkedIn, MOST, COO, Twitter, Partnership, Treats, Consultant, Compliance, PDT, NEO, App store, Cannabis, Public opinion, View, Legislation, Kanha, Holding company, App Store (iOS/iPadOS), Commerce, Drug, Online shopping, Grocery store, Tutoring

The retail location will cater to the Central Valley by offering the communities of Hanford and Fresno weekly special menus and daily demos and deals from top brands.

Key Points: 
  • The retail location will cater to the Central Valley by offering the communities of Hanford and Fresno weekly special menus and daily demos and deals from top brands.
  • DELI by Caliva stores are modeled after old school delicatessens, with every detail from ticketed numbers to the iconic deli countertop to bar stools all in place.
  • "Caliva is proud to be a part of the Central Valley community and is excited to be providing greater access to The Parent Company's high quality, trusted cannabis products with the opening of this retail location," shared Dennis O'Malley, COO of The Parent Company.
  • In honor of the new Central Valley retail location, DELI by Caliva will hold an official ribbon cutting ceremony to mark their grand opening today, August 13 at 11:00 am PDT.

BGP Acquisition Corp. Statement Regarding Recent Media Coverage

Retrieved on: 
Thursday, August 12, 2021
Time, NEO, Corporation, Acquisition, Legislation

VANCOUVER, BC, Aug. 12, 2021 /CNW/ - BGP Acquisition Corp. (NEO: BGP.U) (NEO: BGP.WT.U) (OTCQX: BGPPF) (OTCQX: BGPAF) (the "Corporation") is aware of an article dated today regarding a potential qualifying transaction for the Corporation.

Key Points: 
  • VANCOUVER, BC, Aug. 12, 2021 /CNW/ - BGP Acquisition Corp. (NEO: BGP.U) (NEO: BGP.WT.U) (OTCQX: BGPPF) (OTCQX: BGPAF) (the "Corporation") is aware of an article dated today regarding a potential qualifying transaction for the Corporation.
  • The Corporation confirmed that it is in discussions regarding a qualifying transaction, but has not finalized definitive agreements in respect of a qualifying transaction and will disclose details regarding any potential transaction if and when it is legally required or otherwise appropriate to do so.
  • BGP Acquisition Corp. is a special purpose acquisition corporation incorporated under the laws of the Province of British Columbia for the purpose of effecting, directly or indirectly, a qualifying transaction within a specified period of time.
  • This press release may contain forwardlooking information within the meaning of applicable securities legislation, which reflects the Corporation's current expectations regarding future events.

Awakn Life Sciences Begins Trading on the OTCQB(R) Venture Market Under the Symbol 'AWKNF' on August 12th

Retrieved on: 
Thursday, August 12, 2021
OTC Markets Group, CEO, Achievement, Company, OTC, OTCQB, Compliance, U.S. Securities and Exchange Commission, NEO, SEC, Biotechnology, Awka South, Addiction, Pharmaceutical industry, Security (finance)

The OTCQB is the venture tier of OTC Markets on which 11,000 U.S. and global securities trade.

Key Points: 
  • The OTCQB is the venture tier of OTC Markets on which 11,000 U.S. and global securities trade.
  • Trading on the OTCQB will enhance the visibility and accessibility of the Company to U.S. investors.
  • About Awakn Life Sciences Corp.
    Awakn Life Sciences is a biotechnology company with clinical operations, researching, developing, and delivering psychedelic medicine to better treat Addiction.
  • About OTC Markets Group Inc.
    OTC Markets Group Inc. operates the OTCQX Best Market, the OTCQB Venture Market and the Pink Open Market for 11,000 U.S. and global securities.

REPEAT -- Alkaline Fuel Cell Power Corp. Provides Technology and Target Market Overview

Retrieved on: 
Thursday, August 12, 2021
Climate, GHG, NEO Exchange, Heat, Company, Greenhouse gas, LinkedIn, European Space Agency, Twitter, Hydrogen, GLOBE, NEO, Instagram, Facebook, WKN, Technology, Electricity, Australian Space Agency, CO2, AFCP, Industry, Coal, Renewable energy

VANCOUVER, British Columbia, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Alkaline Fuel Cell Power Corp. (NEO: PWWR) (Frankfurt: 77R, WKN: A3CTYF) ("AFCP" or the "Company"), a company engaged in the development and production of alkaline fuel cell heat and power systems for residential, industrial and commercial markets, today provides an overview on our technology and our target markets.

Key Points: 
  • VANCOUVER, British Columbia, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Alkaline Fuel Cell Power Corp. (NEO: PWWR) (Frankfurt: 77R, WKN: A3CTYF) ("AFCP" or the "Company"), a company engaged in the development and production of alkaline fuel cell heat and power systems for residential, industrial and commercial markets, today provides an overview on our technology and our target markets.
  • The Company is focused on the development, production and commercialization of micro-combined heat and power (micro-CHP) systems based on alkaline fuel cell technology.
  • A fuel cell is a clean electrical power conversion/generation system, akin to small power stations that provide electricity and an equivalent amount of heat for various purposes.
  • Based on hydrogen powered alkaline fuel cell technology, our technology offers an energy source that generates zero CO2 emissions with pure water as the only by-product, making it ideally suited for residential and small- to medium-sized power markets.

Cybin Announces Additional Adelia Milestone Achievements

Retrieved on: 
Thursday, August 12, 2021
Biotechnology, Alternative Medicine, Pharmaceutical, Health, Class, SEDAR, Health Canada, News, EDGAR, Psilocybin, Therapy, Class B share, Safety, Goal, Food, Protocol, Lists of diseases, NEO, Company, Growth, U.S. Securities and Exchange Commission, Research, Risk, Regulation of tobacco by the U.S. Food and Drug Administration, NYSE, Time, Revlon, Inc. v. MacAndrews & Forbes Holdings, Inc., Disease, COVID-19, Inc., Pharmaceutical industry, Biotechnology, Alternative Medicine, Pharmaceutical, Health, Cybin, Adelia, CYBIN, ADELIA

Cybin Inc. ( NEO:CYBN ) (NYSE AMERICAN:CYBN) (Cybin or the Company), a biotechnology company focused on psychedelic pharmaceutical therapies, is pleased to announce that Adelia Therapeutics Inc. (Adelia), a wholly-controlled subsidiary of Cybin, has achieved certain milestones for Year 1 Q3 (i)-(iii), and Year 1 Q4 (iii), as contemplated by the terms of a contribution agreement dated December 4, 2020 (the Transaction Agreement) among Cybin, Cybin Corp., Cybin US Holdings Inc. (the Acquiror), a wholly-controlled subsidiary of Cybin, and all of the previous shareholders of Adelia (the Adelia Shareholders).

Key Points: 
  • Cybin Inc. ( NEO:CYBN ) (NYSE AMERICAN:CYBN) (Cybin or the Company), a biotechnology company focused on psychedelic pharmaceutical therapies, is pleased to announce that Adelia Therapeutics Inc. (Adelia), a wholly-controlled subsidiary of Cybin, has achieved certain milestones for Year 1 Q3 (i)-(iii), and Year 1 Q4 (iii), as contemplated by the terms of a contribution agreement dated December 4, 2020 (the Transaction Agreement) among Cybin, Cybin Corp., Cybin US Holdings Inc. (the Acquiror), a wholly-controlled subsidiary of Cybin, and all of the previous shareholders of Adelia (the Adelia Shareholders).
  • The Class B Shares issued by the Acquiror to the Adelia Shareholders are exchangeable for common shares in the capital of Cybin (the Cybin Shares) on a 10 Cybin Shares for 1 Class B Share basis, at the option of the holder thereof, subject to customary adjustments.
  • Adelia is a wholly-controlled subsidiary of the Company, that aims to develop medicinal psychedelics with improved dosing efficacy and therapeutic indices to address unmet medical needs.
  • Any references to quality, consistency, efficacy and safety of potential products do not imply that Cybin verified such in clinical trials or that Cybin will complete such trials.

DeFi Technologies Announces LOI to Acquire Protos Asset Management GmbH

Retrieved on: 
Thursday, August 12, 2021
Bitcoin, LOI, Cryptocurrency, Family, Letter, Ownership, Acquisition, NEO, EST, Company, Growth, Risk, BTC, OTC, ETH, Decentralized finance, Financial services, Management

TORONTO, Aug. 12, 2021 /PRNewswire/ -DeFi Technologies Inc.(the "Company" or "DeFi Technologies") (NEO: DEFI) (GR: RMJR) (OTC: DEFTF) is pleased to announce that it has entered into a letter of intent (the "LOI") to acquire 100% of the issued and outstanding securities of Protos Asset Management GmbH ("Protos") (the "Protos Acquisition").

Key Points: 
  • TORONTO, Aug. 12, 2021 /PRNewswire/ -DeFi Technologies Inc.(the "Company" or "DeFi Technologies") (NEO: DEFI) (GR: RMJR) (OTC: DEFTF) is pleased to announce that it has entered into a letter of intent (the "LOI") to acquire 100% of the issued and outstanding securities of Protos Asset Management GmbH ("Protos") (the "Protos Acquisition").
  • Wouter Witvoet, DeFi Technologies Chief Executive Officer stated, "Since 2017, the team at Protos have created excellent infrastructure to give institutional and individual investors access to a diversified DeFi portfolio.
  • Thomas Kineshanko, co-founder of Protos stated, "We believe that the combined strengths of DeFi Technologies and Protos will allow us to offer a portfolio of the highest quality DeFi products under one roof.
  • Through the Protos Acquisition, DeFi Technologies will have ownership of the operating business, all intellectual property, and brand of Protos and will assume the core operating team of Protos.

Alkaline Fuel Cell Power Corp. Provides Technology and Target Market Overview

Retrieved on: 
Thursday, August 12, 2021
Heat, Electricity, Facebook, GHG, AFCP, GLOBE, Company, European Space Agency, Instagram, CO2, Climate, Industry, Australian Space Agency, Technology, Greenhouse gas, WKN, LinkedIn, Twitter, NEO Exchange, Hydrogen, NEO, Coal, Renewable energy

VANCOUVER, British Columbia, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Alkaline Fuel Cell Power Corp. (NEO: PWWR) (Frankfurt: 77R, WKN: A3CTYF) ("AFCP" or the "Company"), a company engaged in the development and production of alkaline fuel cell heat and power systems for residential, industrial and commercial markets, today provides an overview on our technology and our target markets.

Key Points: 
  • VANCOUVER, British Columbia, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Alkaline Fuel Cell Power Corp. (NEO: PWWR) (Frankfurt: 77R, WKN: A3CTYF) ("AFCP" or the "Company"), a company engaged in the development and production of alkaline fuel cell heat and power systems for residential, industrial and commercial markets, today provides an overview on our technology and our target markets.
  • The Company is focused on the development, production and commercialization of micro-combined heat and power (micro-CHP) systems based on alkaline fuel cell technology.
  • A fuel cell is a clean electrical power conversion/generation system, akin to small power stations that provide electricity and an equivalent amount of heat for various purposes.
  • Based on hydrogen powered alkaline fuel cell technology, our technology offers an energy source that generates zero CO2 emissions with pure water as the only by-product, making it ideally suited for residential and small- to medium-sized power markets.

Join Nextech AR for a Metaverse Discussion - Featuring CEO Evan Gappelberg During a Proactive Livestream on August 11, 2021

Retrieved on: 
Wednesday, August 11, 2021
Software, Audio, Video, Public Relations, Investor Relations, Advertising, Communications, Technology, Mobile, Wireless, Other Technology, E-commerce, Company, LinkedIn, Instagram, Public expenditure, 3D, YouTube, N29, CSE, Unity, Solution, Forward-looking statement, VCM, Phrase, Learning, AR, Iveco Bus, Twitter, NEO, Legislation, Awareness, Board, SDK, Acquisition, NTAR, FSE, Online shopping, ARway:, Nextech AR, ARWAY:, NEXTECH AR

This acquisition provides Nextech with a spatial mapping platform critical to building the Metaverse.

Key Points: 
  • This acquisition provides Nextech with a spatial mapping platform critical to building the Metaverse.
  • After registering, you will receive a confirmation email containing information about joining the livestream.
  • ARWAY provides users with an Augmented Reality Software Kit (SDK) to frame the digital world in a few minutes.
  • Nextech focuses on developing AR solutions however most of the Companys revenues are derived from three e-Commerce platforms: vacuumcleanermarket.com (VCM), infinitepetlife.com (IPL) and Trulyfesupplements.com (TruLyfe).